0001209191-22-034895.txt : 20220607 0001209191-22-034895.hdr.sgml : 20220607 20220607181708 ACCESSION NUMBER: 0001209191-22-034895 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220603 FILED AS OF DATE: 20220607 DATE AS OF CHANGE: 20220607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verstandig Grant CENTRAL INDEX KEY: 0001843817 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40045 FILM NUMBER: 221002188 MAIL ADDRESS: STREET 1: C/O NEXIMMUNE, INC. STREET 2: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20877 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NexImmune, Inc. CENTRAL INDEX KEY: 0001538210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-825-9810 MAIL ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-03 0 0001538210 NexImmune, Inc. NEXI 0001843817 Verstandig Grant C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 1 0 0 0 Common Stock 2022-06-07 4 P 0 26876 2.284 A 1105495 D Common Stock 2022-06-06 4 P 0 25000 2.1415 A 1078619 D Common Stock 2022-06-03 4 P 0 15000 2.2249 A 1053619 D The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.45, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Excludes 17,376 shares of common stock underlying options that are currently exercisable. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.28, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. /s/ Andrew Pearce, Attorney-in-fact 2022-06-07